tiprankstipranks
Trending News
More News >
Adagio Medical Holdings (ADGM)
NASDAQ:ADGM
US Market
Advertisement

Adagio Medical Holdings (ADGM) Ratios

Compare
32 Followers

Adagio Medical Holdings Ratios

ADGM's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, ADGM's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.89 0.11 0.02 0.15
Quick Ratio
2.51 0.04 -0.04 0.09
Cash Ratio
2.16 0.03 0.01 0.08
Solvency Ratio
-2.09 -0.77 -0.11 -0.59
Operating Cash Flow Ratio
-4.96 -0.53 -0.08 -0.18
Short-Term Operating Cash Flow Coverage
-113.31 -0.65 -4.04 0.00
Net Current Asset Value
$ -11.57M$ -43.75M$ -8.74M$ -10.35M
Leverage Ratios
Debt-to-Assets Ratio
0.45 5.85 <0.01 0.00
Debt-to-Equity Ratio
1.50 -0.95 <0.01 0.00
Debt-to-Capital Ratio
0.60 -18.54 <0.01 0.00
Long-Term Debt-to-Capital Ratio
0.60 >-0.01 0.00 0.00
Financial Leverage Ratio
3.33 -0.16 1.06 1.08
Debt Service Coverage Ratio
186.84 -0.66 -91.12 0.00
Interest Coverage Ratio
104.63 -16.84 -7.37 0.00
Debt to Market Cap
0.82 0.56 <0.01 0.00
Interest Debt Per Share
1.17 5.30 0.01 0.00
Net Debt to EBITDA
-0.08 -1.41 >-0.01 0.03
Profitability Margins
Gross Profit Margin
-620.99%-335.33%-362.96%-328.89%
EBIT Margin
-27674.07%-9314.00%-12452.91%-7384.44%
EBITDA Margin
-30332.51%-9136.67%-12390.48%-7260.00%
Operating Profit Margin
-28504.22%-9314.00%-533.90%-2449.71%
Pretax Profit Margin
-25197.59%-12715.33%564.81%-2430.32%
Net Profit Margin
-25197.59%-12715.33%564.81%-2430.32%
Continuous Operations Profit Margin
-21374.65%-12715.33%564.81%-2430.32%
Net Income Per EBT
100.00%100.00%100.00%100.00%
EBT Per EBIT
88.40%136.52%-105.79%99.21%
Return on Assets (ROA)
-148.12%-558.92%0.70%-4.36%
Return on Equity (ROE)
-224.96%90.59%0.75%-4.71%
Return on Capital Employed (ROCE)
-196.04%66.68%-0.69%-4.58%
Return on Invested Capital (ROIC)
-197.27%1301.44%-0.69%-4.58%
Return on Tangible Assets
-300.12%-558.92%0.70%-4.36%
Earnings Yield
-284.05%-53.66%0.61%-3.78%
Efficiency Ratios
Receivables Turnover
243.00 4.23 -0.03 8.18
Payables Turnover
0.62 0.34 0.87 2.00
Inventory Turnover
0.71 0.39 2.38 3.47
Fixed Asset Turnover
0.08 0.19 0.10 0.16
Asset Turnover
<0.01 0.04 <0.01 <0.01
Working Capital Turnover Ratio
0.02 -0.01 -0.03 -0.10
Cash Conversion Cycle
-73.14 -55.59 -12.99K -32.30
Days of Sales Outstanding
1.50 86.38 -12.72K 44.61
Days of Inventory Outstanding
511.62 928.43 153.09 105.28
Days of Payables Outstanding
586.26 1.07K 421.73 182.18
Operating Cycle
513.12 1.01K -12.57K 149.89
Cash Flow Ratios
Operating Cash Flow Per Share
-1.94 -3.27 -0.03 -0.06
Free Cash Flow Per Share
-1.51 -3.31 -0.05 -0.12
CapEx Per Share
0.04 0.04 0.03 0.07
Free Cash Flow to Operating Cash Flow
0.78 1.01 2.03 2.19
Dividend Paid and CapEx Coverage Ratio
-55.08 -75.45 -0.97 -0.84
Capital Expenditure Coverage Ratio
-55.08 -75.45 -0.97 -0.84
Operating Cash Flow Coverage Ratio
-1.60 -0.64 -4.04 0.00
Operating Cash Flow to Sales Ratio
-122.64 -85.51 -2.57 -3.96
Free Cash Flow Yield
-107.72%-36.56%-0.57%-1.35%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.37 -1.86 162.66 -26.46
Price-to-Sales (P/S) Ratio
93.68 236.98 918.72 643.10
Price-to-Book (P/B) Ratio
1.84 -1.69 1.22 1.25
Price-to-Free Cash Flow (P/FCF) Ratio
-0.98 -2.74 -175.89 -74.14
Price-to-Operating Cash Flow Ratio
-0.76 -2.77 -357.87 -162.26
Price-to-Earnings Growth (PEG) Ratio
0.03 <0.01 -1.40 >-0.01
Price-to-Fair Value
1.84 -1.69 1.22 1.25
Enterprise Value Multiple
-0.39 -4.00 -7.42 -8.83
Enterprise Value
27.19M 109.67M 173.67M 173.14M
EV to EBITDA
-0.37 -4.00 -7.42 -8.83
EV to Sales
111.87 365.55 918.87 641.25
EV to Free Cash Flow
-1.17 -4.22 -175.92 -73.92
EV to Operating Cash Flow
-0.91 -4.28 -357.93 -161.79
Tangible Book Value Per Share
-0.56 -5.36 7.45 7.26
Shareholders’ Equity Per Share
0.81 -5.36 7.45 7.26
Tax and Other Ratios
Effective Tax Rate
-0.01 0.00 0.00 0.00
Revenue Per Share
0.02 0.04 <0.01 0.01
Net Income Per Share
-3.98 -4.86 0.06 -0.34
Tax Burden
1.00 1.00 1.00 1.00
Interest Burden
0.91 1.37 -0.05 0.33
Research & Development to Revenue
45.92 51.33 94.47 56.87
SG&A to Revenue
2.52 15.84 5.34 24.50
Stock-Based Compensation to Revenue
4.82 1.47 1.93 1.26
Income Quality
0.35 0.67 -0.45 0.16
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis